health
New Strides in Bladder Cancer Treatment: Immunotherapy in Focus
Patients with bladder cancer in Serbia have been waiting for years for modern therapeutic options that have already become part of standard treatment in many countries. Today, with important progress made in improving treatment, patients and doctors warn that the fight must not stop, as a large number of patients are still waiting for their chance for more modern treatment.
TL;DR
- Serbia is improving bladder cancer treatment with new therapeutic options, including immunotherapy.
- A campaign 'Patient Voice, Medicine Tailored to Us' is raising awareness about bladder cancer and treatment challenges.
- Bladder cancer affects approximately 2,500 people annually in Serbia, with over 1,000 deaths.
- Smoking is a major risk factor for bladder cancer, alongside chemical exposure and chronic infections.
- Early detection, particularly blood in urine, is crucial for better treatment outcomes.
- New therapies, including a combination of chemotherapy and immunotherapy, are becoming available for certain stages of the disease.
- Immunotherapy is recognized as a standard treatment in international guidelines for various stages of bladder cancer.
- Patient advocacy groups are pushing for continued progress to ensure all patients have access to modern treatments.
- A declaration 'Patient Voice: Medicine Tailored to Us' has been signed to promote ongoing treatment improvements.